至今,GenScript的服务及产品已被Cell, Nature, Science, PNAS等1300多家生物医药类杂志引用近万次,处于行业领先水平。NIH、哈佛、耶鲁、斯坦福、普林斯顿、杜克大学等约400家全球著名机构使用GenScript的基因合成、多肽服务、抗体服务和蛋白服务等成功地发表科研成果,再次证明GenScript 有能力帮助业内科学家Make research easy.

Connexin43 recruits PTEN and Csk to inhibit c-Src activity in glioma cells and astrocytes.

Oncotarget. 2016-03; 
González-SánchezAna,Jaraíz-RodríguezMyriam,Domínguez-PrietoMarta,Herrero-GonzálezSandra,MedinaJosé M,TaberneroAra
Products/Services Used Details Operation
Peptide Synthesis The synthetic peptides (> 90% pure) were obtained from GenScript (Piscataway, NJ, USA). Get A Quote

摘要

Connexin43 (Cx43), the major protein forming gap junctions in astrocytes, is reduced in high-grade gliomas, where its ectopic expression exerts important effects, including the inhibition of the proto-oncogene tyrosine-protein kinase Src (c-Src). In this work we aimed to investigate the mechanism responsible for this effect. The inhibition of c-Src requires phosphorylation at tyrosine 527 mediated by C-terminal Src kinase (Csk) and dephosphorylation at tyrosine 416 mediated by phosphatases, such as phosphatase and tensin homolog (PTEN). Our results showed that the antiproliferative effect of Cx43 is reduced when Csk and PTEN are silenced in glioma cells, suggesting the involvement of both enzymes. C... More

关键词

CNS,Src,connexin,gap junctions,